These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1389948)

  • 21. Severe accidental dapsone overdose.
    McGoldrick MD; Bailie GR
    Am J Emerg Med; 1995 Jul; 13(4):414-5. PubMed ID: 7605525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.
    Coleman MD
    Br J Dermatol; 1993 Nov; 129(5):507-13. PubMed ID: 8251346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapsone toxicity: some current perspectives.
    Coleman MD
    Gen Pharmacol; 1995 Nov; 26(7):1461-7. PubMed ID: 8690232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of dapsone-induced methaemoglobinaemia in the rat.
    Coleman MD; Winn MJ; Breckenridge AM; Park BK
    Biochem Pharmacol; 1990 Feb; 39(4):802-5. PubMed ID: 2306285
    [No Abstract]   [Full Text] [Related]  

  • 25. Possible dapsone-induced peripheral neuropathy in dermatitis herpetiformis.
    du Vivier A; Fowler T
    Proc R Soc Med; 1974 Jun; 67(6 Pt 1):439-40. PubMed ID: 4369028
    [No Abstract]   [Full Text] [Related]  

  • 26. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glutathione reductase deficiency in Duhring's dermatitis herpetiformis].
    Benöhr HC; Huelsekopf D; Kohn R
    Hautarzt; 1973 Aug; 24(8):347-50. PubMed ID: 4741271
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term combination therapy of ustekinumab and dapsone in a patient with psoriasis and dermatitis herpetiformis Duhring.
    Gkalpakiotis S; Arenberger P; Sticova E; Sefrnova P; Arenbergerova M
    J Dermatol; 2012 Dec; 39(12):1074-5. PubMed ID: 22784106
    [No Abstract]   [Full Text] [Related]  

  • 29. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 30. "Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis.
    Katz SI
    Arch Dermatol; 1982 Oct; 118(10):805-12. PubMed ID: 6753759
    [No Abstract]   [Full Text] [Related]  

  • 31. [Polyneuropathy in Duhring dermatitis herpetiformis].
    Dillmann U; Krämer G; Goebel HH
    Nervenarzt; 1991 Aug; 62(8):516-8. PubMed ID: 1944718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe dapsone hypersensitivity syndrome.
    Sener O; Doganci L; Safali M; Besirbellioglu B; Bulucu F; Pahsa A
    J Investig Allergol Clin Immunol; 2006; 16(4):268-70. PubMed ID: 16889287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia.
    Ashurst JV; Wasson MN; Hauger W; Fritz WT
    J Am Osteopath Assoc; 2010 Jan; 110(1):16-20. PubMed ID: 20093649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptomatic rebound methaemoglobinaemia after treatment with dapsone.
    Jonkers BRP; Cobanoglu G; Blok EJ; Köbben JJ; van der Helm MW; van Hoof IJAM; Tintu AN; Bethlehem C; Versmissen J
    Neth J Med; 2020 Sep; 78(5):277-281. PubMed ID: 33093248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone.
    Zemtsov A; Neldner KH
    J Am Acad Dermatol; 1993 Mar; 28(3):505-6. PubMed ID: 8445075
    [No Abstract]   [Full Text] [Related]  

  • 37. Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia.
    Mayo W; Leighton K; Robertson B; Ruedy J
    Can J Anaesth; 1987 Jan; 34(1):79-82. PubMed ID: 3829290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid.
    McFadden JP; Leonard JN; Powles AV; Rutman AJ; Fry L
    Br J Dermatol; 1989 Dec; 121(6):759-62. PubMed ID: 2692691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manic depression induced by dapsone in patient with dermatitis herpetiformis.
    Gawkrodger D
    BMJ; 1989 Sep; 299(6703):860. PubMed ID: 2510873
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaemia in dermatitis herpetiformis. The role of dapsone-induced haemolysis and malabsorption.
    Cream JJ; Scott GL
    Br J Dermatol; 1970 Apr; 82(4):333-42. PubMed ID: 5441766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.